Page 42 - Medication Guide News Today

Confirmatory trial's completion is expected in an accelerated timeline of four years with patient screening to start in MayMultiple strategies in place to enroll patients that are representative of diverse

Confirmatory trial’s completion is expected in an accelerated timeline of four years with patient screening to start in MayMultiple strategies in place to enroll patients that are representative... | March 30, 2022

Ozempic® demonstrated 2.1% blood sugar reduction and also weight loss in adults with type 2 diabetes with new 2 mg dose1PLAINSBORO, N.J., March 28...

(BPT) - By Dr. Greg Mattingly, Physician and Principal Investigator in clinical trials for Midwest Research Group

-- AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectru...

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has entered into a definitive agreement to divest Sunosi® (solriamfetol), a...

/PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a 2 mg dose of Ozempic® (semaglutide) injection, a...

Opinion Granted Based on Positive Results From Phase 3 KEYNOTE-826 Trial Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency's Committee

Press release content from PR Newswire. The AP news staff was not involved in its creation.

70% of women diagnosed with breast cancer report having sexual dysfunction; there are currently a lack of effective treatment options for these wo...